Key Insights
The Advanced Therapy Medicinal Products (ATMP) Contract Development and Manufacturing Organization (CDMO) market is experiencing explosive growth, projected to reach \$6.04 billion in 2025 and maintain a robust Compound Annual Growth Rate (CAGR) of 24.40% from 2025 to 2033. This surge is driven by the increasing demand for personalized medicines, particularly cell and gene therapies, fueled by advancements in research and development and a growing number of clinical trials demonstrating efficacy for various diseases. Key drivers include the rising prevalence of chronic conditions like cancer and autoimmune diseases, increased regulatory approvals for ATMPs, and significant investments in research and development from both public and private sectors. The market's expansion is further propelled by strategic collaborations and mergers & acquisitions among major players, aiming to consolidate capabilities and expand market share. Technological innovations such as improved cell engineering techniques, advanced delivery systems, and innovative manufacturing processes are also contributing significantly to this growth. The competitive landscape features a mix of large established CDMOs and specialized smaller companies, with prominent players including Lonza, Catalent, and WuXi Advanced Therapies actively shaping the market dynamics.
The segment analysis, while not explicitly provided, can be reasonably inferred. The market is likely segmented by therapy type (e.g., cell therapy, gene therapy), service offered (e.g., process development, manufacturing), and geographic region. Geographic segmentation will likely show strong growth in North America and Europe initially, followed by a rise in Asia-Pacific driven by increasing healthcare spending and a growing biotech sector in regions like China and India. Market restraints include the high cost of development and manufacturing, stringent regulatory hurdles, and the complexities associated with scaling up ATMP production to meet rising global demand. Despite these challenges, the long-term outlook for the ATMP CDMO market remains incredibly positive, driven by the transformative potential of these innovative therapies.
-CDMO-Market.png)
Advanced Therapy Medicinal Products (ATMP) CDMO Market Report: 2019-2033
This comprehensive report provides an in-depth analysis of the Advanced Therapy Medicinal Products (ATMP) Contract Development and Manufacturing Organization (CDMO) market, covering the period 2019-2033. It delves into market dynamics, growth trends, regional dominance, product landscapes, and key players, offering crucial insights for industry professionals, investors, and strategic decision-makers. The report forecasts a market valued at xx Million by 2033, fueled by the burgeoning cell and gene therapy industry.
Advanced Therapy Medicinal Products (ATMP) CDMO Market Dynamics & Structure
The ATMP CDMO market is experiencing rapid growth, driven by the increasing demand for advanced therapies like cell and gene therapies. Market concentration is moderately high, with a few large players dominating alongside a growing number of specialized smaller CDMOs. Technological innovation, particularly in areas such as process automation and single-use technologies, are key drivers. Stringent regulatory frameworks, however, pose challenges, necessitating significant investment in compliance. The market also faces competitive pressures from established pharmaceutical CDMOs expanding into the ATMP space. Mergers and acquisitions (M&A) activity is significant, with larger players acquiring smaller, specialized firms to expand their service offerings and capabilities.
- Market Concentration: Moderately high, with top 5 players holding approximately xx% market share in 2024.
- Technological Innovation: Focus on automation, single-use systems, and process analytical technology (PAT) to improve efficiency and reduce costs.
- Regulatory Landscape: Stringent regulatory requirements for ATMPs create high barriers to entry and necessitate significant investment in compliance.
- Competitive Landscape: Intense competition from both specialized ATMP CDMOs and larger pharmaceutical CDMOs expanding into this niche.
- M&A Activity: Significant M&A activity observed in the historical period (2019-2024), with an estimated xx deals annually.
- Innovation Barriers: High capital investment required for facility setup and validation, along with specialized expertise in handling complex ATMP manufacturing processes.
Advanced Therapy Medicinal Products (ATMP) CDMO Market Growth Trends & Insights
The ATMP CDMO market is experiencing robust growth, with a Compound Annual Growth Rate (CAGR) of xx% projected from 2025 to 2033. This growth is fueled by the increasing number of ATMP clinical trials and approvals, alongside the rising investments in cell and gene therapy research and development. The market's adoption rate is rapidly increasing, driven by the outsourcing trend among biotech and pharmaceutical companies. Technological disruptions, such as the development of closed-system manufacturing and advanced analytics, further accelerate market expansion. Shifting consumer preferences towards personalized and targeted therapies also contribute to the increased demand for ATMP CDMO services. The market penetration rate is expected to reach xx% by 2033.
-CDMO-Market.png)
Dominant Regions, Countries, or Segments in Advanced Therapy Medicinal Products (ATMP) CDMO Market
North America currently holds the largest market share, driven by robust funding for biotech and pharma research, a well-established regulatory framework, and a high concentration of ATMP companies. Europe follows closely, benefiting from a strong life sciences ecosystem and government initiatives supporting ATMP development. The Asia-Pacific region is also exhibiting rapid growth, driven by increased investments and growing awareness of advanced therapies.
- North America: High market share due to significant R&D spending, established regulatory environment and strong presence of major CDMOs.
- Europe: Strong life sciences ecosystem and supportive government policies contribute to market growth.
- Asia-Pacific: Rapid expansion driven by increased investments, growing awareness, and favorable government regulations.
- Key Drivers: Government funding, supportive regulatory frameworks, and robust R&D investments within each region.
Advanced Therapy Medicinal Products (ATMP) CDMO Market Product Landscape
The ATMP CDMO market offers a diverse range of services, including process development, analytical testing, manufacturing, and packaging of various ATMP modalities, such as cell therapies, gene therapies, and other advanced therapies. Product innovations focus on improving efficiency, scalability, and reducing manufacturing costs. Key advancements include automation, single-use technologies, and closed-system manufacturing, ensuring higher quality and reduced contamination risks. Unique selling propositions are centered around speed, flexibility, compliance, and specialized expertise in handling complex ATMPs.
Key Drivers, Barriers & Challenges in Advanced Therapy Medicinal Products (ATMP) CDMO Market
Key Drivers:
- Increasing demand for cell and gene therapies.
- Growing number of ATMP clinical trials and approvals.
- Technological advancements in manufacturing processes.
- Outsourcing trend among biotech and pharma companies.
Challenges & Restraints:
- High capital investment for facility setup and validation.
- Stringent regulatory requirements and compliance costs.
- Skilled labor shortages in the ATMP manufacturing sector.
- Potential supply chain disruptions impacting raw materials and equipment.
Emerging Opportunities in Advanced Therapy Medicinal Products (ATMP) CDMO Market
- Expansion into emerging markets with growing demand for advanced therapies.
- Development of specialized services for novel ATMP modalities.
- Adoption of advanced technologies such as AI and machine learning to enhance efficiency and reduce costs.
- Strategic partnerships to broaden service offerings and access new markets.
Growth Accelerators in the Advanced Therapy Medicinal Products (ATMP) CDMO Market Industry
Technological advancements, such as the development of automated and closed systems, and improved analytics, are driving significant efficiency gains and accelerating market growth. Strategic partnerships between CDMOs and ATMP developers foster collaboration and expedite the development and commercialization of new therapies. Expansion into emerging markets and the development of new service offerings, catering to evolving demands, are also contributing factors.
Key Players Shaping the Advanced Therapy Medicinal Products (ATMP) CDMO Market Market
- Cell and Gene Therapy Catapult (CGT Catapult)
- Patheon Inc
- CELONIC Group
- Bio Elpida
- AGC Biologics
- Rentschler Biopharma SE
- WuXi Advanced Therapies
- Lonza
- Catalent Inc
- Minaris Regenerative Medicine
- *List Not Exhaustive
Notable Milestones in Advanced Therapy Medicinal Products (ATMP) CDMO Market Sector
- January 2024: Pluri launched its PluriCDMO division, a 47,000 sq ft GMP cell therapy production facility. This significantly expands capacity for cell therapy manufacturing.
- January 2024: Charles River Laboratories launched its off-the-shelf Rep/Cap plasmid offering, streamlining AAV-based gene therapy development. This innovation accelerates gene therapy development timelines.
In-Depth Advanced Therapy Medicinal Products (ATMP) CDMO Market Market Outlook
The ATMP CDMO market is poised for sustained growth, driven by the continued expansion of the ATMP pipeline and increased investments in advanced therapies. Strategic partnerships, technological advancements, and expansion into emerging markets will be key factors driving long-term market success. Opportunities exist for CDMOs that can offer comprehensive services, leveraging advanced technologies and adhering to the stringent regulatory requirements. The market's future is bright, with significant potential for innovation and expansion.
Advanced Therapy Medicinal Products (ATMP) CDMO Market Segmentation
-
1. Product
- 1.1. Gene Therapy
- 1.2. Cell Therapy
- 1.3. Tissue Engineering
- 1.4. Other Products
-
2. Phase
- 2.1. Phase I
- 2.2. Phase II
- 2.3. Phase III
- 2.4. Phase IV
-
3. Indication
- 3.1. Oncology
- 3.2. Cardiology
- 3.3. Neurology
- 3.4. Infectious Disease
- 3.5. Other Indications
Advanced Therapy Medicinal Products (ATMP) CDMO Market Segmentation By Geography
-
1. North America
- 1.1. United States
- 1.2. Canada
- 1.3. Mexico
-
2. Europe
- 2.1. Germany
- 2.2. United Kingdom
- 2.3. France
- 2.4. Italy
- 2.5. Spain
- 2.6. Rest of Europe
-
3. Asia Pacific
- 3.1. China
- 3.2. Japan
- 3.3. India
- 3.4. Australia
- 3.5. South Korea
- 3.6. Rest of Asia Pacific
-
4. Middle East and Africa
- 4.1. GCC
- 4.2. South Africa
- 4.3. Rest of Middle East and Africa
-
5. South America
- 5.1. Brazil
- 5.2. Argentina
- 5.3. Rest of South America
-CDMO-Market.png)
Advanced Therapy Medicinal Products (ATMP) CDMO Market REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2019-2033 |
| Base Year | 2024 |
| Estimated Year | 2025 |
| Forecast Period | 2025-2033 |
| Historical Period | 2019-2024 |
| Growth Rate | CAGR of 24.40% from 2019-2033 |
| Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Increasing Clinical Trials in ATMP; Growing Demand for Outsourcing in Pharmaceutical Industry
- 3.3. Market Restrains
- 3.3.1. Increasing Clinical Trials in ATMP; Growing Demand for Outsourcing in Pharmaceutical Industry
- 3.4. Market Trends
- 3.4.1. The Gene Therapy Segment is Expected to Hold a Major Market Share During the Forecast Period
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Product
- 5.1.1. Gene Therapy
- 5.1.2. Cell Therapy
- 5.1.3. Tissue Engineering
- 5.1.4. Other Products
- 5.2. Market Analysis, Insights and Forecast - by Phase
- 5.2.1. Phase I
- 5.2.2. Phase II
- 5.2.3. Phase III
- 5.2.4. Phase IV
- 5.3. Market Analysis, Insights and Forecast - by Indication
- 5.3.1. Oncology
- 5.3.2. Cardiology
- 5.3.3. Neurology
- 5.3.4. Infectious Disease
- 5.3.5. Other Indications
- 5.4. Market Analysis, Insights and Forecast - by Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Middle East and Africa
- 5.4.5. South America
- 5.1. Market Analysis, Insights and Forecast - by Product
- 6. North America Advanced Therapy Medicinal Products (ATMP) CDMO Market Analysis, Insights and Forecast, 2019-2031
- 6.1. Market Analysis, Insights and Forecast - by Product
- 6.1.1. Gene Therapy
- 6.1.2. Cell Therapy
- 6.1.3. Tissue Engineering
- 6.1.4. Other Products
- 6.2. Market Analysis, Insights and Forecast - by Phase
- 6.2.1. Phase I
- 6.2.2. Phase II
- 6.2.3. Phase III
- 6.2.4. Phase IV
- 6.3. Market Analysis, Insights and Forecast - by Indication
- 6.3.1. Oncology
- 6.3.2. Cardiology
- 6.3.3. Neurology
- 6.3.4. Infectious Disease
- 6.3.5. Other Indications
- 6.1. Market Analysis, Insights and Forecast - by Product
- 7. Europe Advanced Therapy Medicinal Products (ATMP) CDMO Market Analysis, Insights and Forecast, 2019-2031
- 7.1. Market Analysis, Insights and Forecast - by Product
- 7.1.1. Gene Therapy
- 7.1.2. Cell Therapy
- 7.1.3. Tissue Engineering
- 7.1.4. Other Products
- 7.2. Market Analysis, Insights and Forecast - by Phase
- 7.2.1. Phase I
- 7.2.2. Phase II
- 7.2.3. Phase III
- 7.2.4. Phase IV
- 7.3. Market Analysis, Insights and Forecast - by Indication
- 7.3.1. Oncology
- 7.3.2. Cardiology
- 7.3.3. Neurology
- 7.3.4. Infectious Disease
- 7.3.5. Other Indications
- 7.1. Market Analysis, Insights and Forecast - by Product
- 8. Asia Pacific Advanced Therapy Medicinal Products (ATMP) CDMO Market Analysis, Insights and Forecast, 2019-2031
- 8.1. Market Analysis, Insights and Forecast - by Product
- 8.1.1. Gene Therapy
- 8.1.2. Cell Therapy
- 8.1.3. Tissue Engineering
- 8.1.4. Other Products
- 8.2. Market Analysis, Insights and Forecast - by Phase
- 8.2.1. Phase I
- 8.2.2. Phase II
- 8.2.3. Phase III
- 8.2.4. Phase IV
- 8.3. Market Analysis, Insights and Forecast - by Indication
- 8.3.1. Oncology
- 8.3.2. Cardiology
- 8.3.3. Neurology
- 8.3.4. Infectious Disease
- 8.3.5. Other Indications
- 8.1. Market Analysis, Insights and Forecast - by Product
- 9. Middle East and Africa Advanced Therapy Medicinal Products (ATMP) CDMO Market Analysis, Insights and Forecast, 2019-2031
- 9.1. Market Analysis, Insights and Forecast - by Product
- 9.1.1. Gene Therapy
- 9.1.2. Cell Therapy
- 9.1.3. Tissue Engineering
- 9.1.4. Other Products
- 9.2. Market Analysis, Insights and Forecast - by Phase
- 9.2.1. Phase I
- 9.2.2. Phase II
- 9.2.3. Phase III
- 9.2.4. Phase IV
- 9.3. Market Analysis, Insights and Forecast - by Indication
- 9.3.1. Oncology
- 9.3.2. Cardiology
- 9.3.3. Neurology
- 9.3.4. Infectious Disease
- 9.3.5. Other Indications
- 9.1. Market Analysis, Insights and Forecast - by Product
- 10. South America Advanced Therapy Medicinal Products (ATMP) CDMO Market Analysis, Insights and Forecast, 2019-2031
- 10.1. Market Analysis, Insights and Forecast - by Product
- 10.1.1. Gene Therapy
- 10.1.2. Cell Therapy
- 10.1.3. Tissue Engineering
- 10.1.4. Other Products
- 10.2. Market Analysis, Insights and Forecast - by Phase
- 10.2.1. Phase I
- 10.2.2. Phase II
- 10.2.3. Phase III
- 10.2.4. Phase IV
- 10.3. Market Analysis, Insights and Forecast - by Indication
- 10.3.1. Oncology
- 10.3.2. Cardiology
- 10.3.3. Neurology
- 10.3.4. Infectious Disease
- 10.3.5. Other Indications
- 10.1. Market Analysis, Insights and Forecast - by Product
- 11. Competitive Analysis
- 11.1. Global Market Share Analysis 2024
- 11.2. Company Profiles
- 11.2.1 Cell and Gene Therapy Catapult (CGT Catapult)
- 11.2.1.1. Overview
- 11.2.1.2. Products
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Financials (Based on Availability)
- 11.2.2 Patheon Inc
- 11.2.2.1. Overview
- 11.2.2.2. Products
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Financials (Based on Availability)
- 11.2.3 CELONIC Group
- 11.2.3.1. Overview
- 11.2.3.2. Products
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Financials (Based on Availability)
- 11.2.4 Bio Elpida
- 11.2.4.1. Overview
- 11.2.4.2. Products
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Financials (Based on Availability)
- 11.2.5 AGC Biologics
- 11.2.5.1. Overview
- 11.2.5.2. Products
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Financials (Based on Availability)
- 11.2.6 Rentschler Biopharma SE
- 11.2.6.1. Overview
- 11.2.6.2. Products
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Financials (Based on Availability)
- 11.2.7 WuXi Advanced Therapies
- 11.2.7.1. Overview
- 11.2.7.2. Products
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Financials (Based on Availability)
- 11.2.8 Lonza
- 11.2.8.1. Overview
- 11.2.8.2. Products
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Financials (Based on Availability)
- 11.2.9 Catalent Inc
- 11.2.9.1. Overview
- 11.2.9.2. Products
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Financials (Based on Availability)
- 11.2.10 Minaris Regenerative Medicine*List Not Exhaustive
- 11.2.10.1. Overview
- 11.2.10.2. Products
- 11.2.10.3. SWOT Analysis
- 11.2.10.4. Recent Developments
- 11.2.10.5. Financials (Based on Availability)
- 11.2.1 Cell and Gene Therapy Catapult (CGT Catapult)
List of Figures
- Figure 1: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Breakdown (Million, %) by Region 2024 & 2032
- Figure 2: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Breakdown (Billion, %) by Region 2024 & 2032
- Figure 3: North America Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million), by Product 2024 & 2032
- Figure 4: North America Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion), by Product 2024 & 2032
- Figure 5: North America Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Share (%), by Product 2024 & 2032
- Figure 6: North America Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Share (%), by Product 2024 & 2032
- Figure 7: North America Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million), by Phase 2024 & 2032
- Figure 8: North America Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion), by Phase 2024 & 2032
- Figure 9: North America Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Share (%), by Phase 2024 & 2032
- Figure 10: North America Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Share (%), by Phase 2024 & 2032
- Figure 11: North America Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million), by Indication 2024 & 2032
- Figure 12: North America Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion), by Indication 2024 & 2032
- Figure 13: North America Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Share (%), by Indication 2024 & 2032
- Figure 14: North America Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Share (%), by Indication 2024 & 2032
- Figure 15: North America Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million), by Country 2024 & 2032
- Figure 16: North America Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion), by Country 2024 & 2032
- Figure 17: North America Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Share (%), by Country 2024 & 2032
- Figure 18: North America Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Share (%), by Country 2024 & 2032
- Figure 19: Europe Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million), by Product 2024 & 2032
- Figure 20: Europe Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion), by Product 2024 & 2032
- Figure 21: Europe Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Share (%), by Product 2024 & 2032
- Figure 22: Europe Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Share (%), by Product 2024 & 2032
- Figure 23: Europe Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million), by Phase 2024 & 2032
- Figure 24: Europe Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion), by Phase 2024 & 2032
- Figure 25: Europe Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Share (%), by Phase 2024 & 2032
- Figure 26: Europe Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Share (%), by Phase 2024 & 2032
- Figure 27: Europe Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million), by Indication 2024 & 2032
- Figure 28: Europe Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion), by Indication 2024 & 2032
- Figure 29: Europe Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Share (%), by Indication 2024 & 2032
- Figure 30: Europe Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Share (%), by Indication 2024 & 2032
- Figure 31: Europe Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million), by Country 2024 & 2032
- Figure 32: Europe Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion), by Country 2024 & 2032
- Figure 33: Europe Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Share (%), by Country 2024 & 2032
- Figure 34: Europe Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Share (%), by Country 2024 & 2032
- Figure 35: Asia Pacific Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million), by Product 2024 & 2032
- Figure 36: Asia Pacific Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion), by Product 2024 & 2032
- Figure 37: Asia Pacific Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Share (%), by Product 2024 & 2032
- Figure 38: Asia Pacific Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Share (%), by Product 2024 & 2032
- Figure 39: Asia Pacific Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million), by Phase 2024 & 2032
- Figure 40: Asia Pacific Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion), by Phase 2024 & 2032
- Figure 41: Asia Pacific Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Share (%), by Phase 2024 & 2032
- Figure 42: Asia Pacific Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Share (%), by Phase 2024 & 2032
- Figure 43: Asia Pacific Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million), by Indication 2024 & 2032
- Figure 44: Asia Pacific Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion), by Indication 2024 & 2032
- Figure 45: Asia Pacific Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Share (%), by Indication 2024 & 2032
- Figure 46: Asia Pacific Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Share (%), by Indication 2024 & 2032
- Figure 47: Asia Pacific Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million), by Country 2024 & 2032
- Figure 48: Asia Pacific Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion), by Country 2024 & 2032
- Figure 49: Asia Pacific Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Share (%), by Country 2024 & 2032
- Figure 50: Asia Pacific Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Share (%), by Country 2024 & 2032
- Figure 51: Middle East and Africa Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million), by Product 2024 & 2032
- Figure 52: Middle East and Africa Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion), by Product 2024 & 2032
- Figure 53: Middle East and Africa Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Share (%), by Product 2024 & 2032
- Figure 54: Middle East and Africa Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Share (%), by Product 2024 & 2032
- Figure 55: Middle East and Africa Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million), by Phase 2024 & 2032
- Figure 56: Middle East and Africa Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion), by Phase 2024 & 2032
- Figure 57: Middle East and Africa Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Share (%), by Phase 2024 & 2032
- Figure 58: Middle East and Africa Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Share (%), by Phase 2024 & 2032
- Figure 59: Middle East and Africa Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million), by Indication 2024 & 2032
- Figure 60: Middle East and Africa Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion), by Indication 2024 & 2032
- Figure 61: Middle East and Africa Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Share (%), by Indication 2024 & 2032
- Figure 62: Middle East and Africa Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Share (%), by Indication 2024 & 2032
- Figure 63: Middle East and Africa Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million), by Country 2024 & 2032
- Figure 64: Middle East and Africa Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion), by Country 2024 & 2032
- Figure 65: Middle East and Africa Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Share (%), by Country 2024 & 2032
- Figure 66: Middle East and Africa Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Share (%), by Country 2024 & 2032
- Figure 67: South America Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million), by Product 2024 & 2032
- Figure 68: South America Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion), by Product 2024 & 2032
- Figure 69: South America Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Share (%), by Product 2024 & 2032
- Figure 70: South America Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Share (%), by Product 2024 & 2032
- Figure 71: South America Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million), by Phase 2024 & 2032
- Figure 72: South America Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion), by Phase 2024 & 2032
- Figure 73: South America Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Share (%), by Phase 2024 & 2032
- Figure 74: South America Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Share (%), by Phase 2024 & 2032
- Figure 75: South America Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million), by Indication 2024 & 2032
- Figure 76: South America Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion), by Indication 2024 & 2032
- Figure 77: South America Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Share (%), by Indication 2024 & 2032
- Figure 78: South America Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Share (%), by Indication 2024 & 2032
- Figure 79: South America Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million), by Country 2024 & 2032
- Figure 80: South America Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion), by Country 2024 & 2032
- Figure 81: South America Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Share (%), by Country 2024 & 2032
- Figure 82: South America Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Share (%), by Country 2024 & 2032
List of Tables
- Table 1: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Million Forecast, by Region 2019 & 2032
- Table 2: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Billion Forecast, by Region 2019 & 2032
- Table 3: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Million Forecast, by Product 2019 & 2032
- Table 4: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Billion Forecast, by Product 2019 & 2032
- Table 5: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Million Forecast, by Phase 2019 & 2032
- Table 6: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Billion Forecast, by Phase 2019 & 2032
- Table 7: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Million Forecast, by Indication 2019 & 2032
- Table 8: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Billion Forecast, by Indication 2019 & 2032
- Table 9: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Million Forecast, by Region 2019 & 2032
- Table 10: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Billion Forecast, by Region 2019 & 2032
- Table 11: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Million Forecast, by Product 2019 & 2032
- Table 12: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Billion Forecast, by Product 2019 & 2032
- Table 13: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Million Forecast, by Phase 2019 & 2032
- Table 14: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Billion Forecast, by Phase 2019 & 2032
- Table 15: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Million Forecast, by Indication 2019 & 2032
- Table 16: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Billion Forecast, by Indication 2019 & 2032
- Table 17: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Million Forecast, by Country 2019 & 2032
- Table 18: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Billion Forecast, by Country 2019 & 2032
- Table 19: United States Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 20: United States Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 21: Canada Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 22: Canada Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 23: Mexico Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 24: Mexico Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 25: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Million Forecast, by Product 2019 & 2032
- Table 26: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Billion Forecast, by Product 2019 & 2032
- Table 27: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Million Forecast, by Phase 2019 & 2032
- Table 28: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Billion Forecast, by Phase 2019 & 2032
- Table 29: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Million Forecast, by Indication 2019 & 2032
- Table 30: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Billion Forecast, by Indication 2019 & 2032
- Table 31: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Million Forecast, by Country 2019 & 2032
- Table 32: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Billion Forecast, by Country 2019 & 2032
- Table 33: Germany Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 34: Germany Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 35: United Kingdom Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 36: United Kingdom Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 37: France Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 38: France Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 39: Italy Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 40: Italy Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 41: Spain Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 42: Spain Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 43: Rest of Europe Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 44: Rest of Europe Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 45: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Million Forecast, by Product 2019 & 2032
- Table 46: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Billion Forecast, by Product 2019 & 2032
- Table 47: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Million Forecast, by Phase 2019 & 2032
- Table 48: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Billion Forecast, by Phase 2019 & 2032
- Table 49: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Million Forecast, by Indication 2019 & 2032
- Table 50: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Billion Forecast, by Indication 2019 & 2032
- Table 51: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Million Forecast, by Country 2019 & 2032
- Table 52: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Billion Forecast, by Country 2019 & 2032
- Table 53: China Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 54: China Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 55: Japan Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 56: Japan Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 57: India Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 58: India Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 59: Australia Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 60: Australia Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 61: South Korea Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 62: South Korea Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 63: Rest of Asia Pacific Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 64: Rest of Asia Pacific Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 65: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Million Forecast, by Product 2019 & 2032
- Table 66: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Billion Forecast, by Product 2019 & 2032
- Table 67: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Million Forecast, by Phase 2019 & 2032
- Table 68: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Billion Forecast, by Phase 2019 & 2032
- Table 69: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Million Forecast, by Indication 2019 & 2032
- Table 70: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Billion Forecast, by Indication 2019 & 2032
- Table 71: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Million Forecast, by Country 2019 & 2032
- Table 72: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Billion Forecast, by Country 2019 & 2032
- Table 73: GCC Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 74: GCC Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 75: South Africa Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 76: South Africa Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 77: Rest of Middle East and Africa Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 78: Rest of Middle East and Africa Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 79: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Million Forecast, by Product 2019 & 2032
- Table 80: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Billion Forecast, by Product 2019 & 2032
- Table 81: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Million Forecast, by Phase 2019 & 2032
- Table 82: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Billion Forecast, by Phase 2019 & 2032
- Table 83: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Million Forecast, by Indication 2019 & 2032
- Table 84: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Billion Forecast, by Indication 2019 & 2032
- Table 85: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue Million Forecast, by Country 2019 & 2032
- Table 86: Global Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume Billion Forecast, by Country 2019 & 2032
- Table 87: Brazil Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 88: Brazil Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 89: Argentina Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 90: Argentina Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion) Forecast, by Application 2019 & 2032
- Table 91: Rest of South America Advanced Therapy Medicinal Products (ATMP) CDMO Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 92: Rest of South America Advanced Therapy Medicinal Products (ATMP) CDMO Market Volume (Billion) Forecast, by Application 2019 & 2032
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Advanced Therapy Medicinal Products (ATMP) CDMO Market?
The projected CAGR is approximately 24.40%.
2. Which companies are prominent players in the Advanced Therapy Medicinal Products (ATMP) CDMO Market?
Key companies in the market include Cell and Gene Therapy Catapult (CGT Catapult), Patheon Inc, CELONIC Group, Bio Elpida, AGC Biologics, Rentschler Biopharma SE, WuXi Advanced Therapies, Lonza, Catalent Inc, Minaris Regenerative Medicine*List Not Exhaustive.
3. What are the main segments of the Advanced Therapy Medicinal Products (ATMP) CDMO Market?
The market segments include Product, Phase, Indication.
4. Can you provide details about the market size?
The market size is estimated to be USD 6.04 Million as of 2022.
5. What are some drivers contributing to market growth?
Increasing Clinical Trials in ATMP; Growing Demand for Outsourcing in Pharmaceutical Industry.
6. What are the notable trends driving market growth?
The Gene Therapy Segment is Expected to Hold a Major Market Share During the Forecast Period.
7. Are there any restraints impacting market growth?
Increasing Clinical Trials in ATMP; Growing Demand for Outsourcing in Pharmaceutical Industry.
8. Can you provide examples of recent developments in the market?
January 2024: Pluri, an Israel-based biotech company, introduced its new division named PluriCDMO, which offers cell therapy manufacturing services as a contract development and manufacturing organization (CDMO). The new division includes a 47,000-square-foot good manufacturing practice (GMP) cell therapy production facility.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 5250, and USD 8750 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million and volume, measured in Billion.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Advanced Therapy Medicinal Products (ATMP) CDMO Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Advanced Therapy Medicinal Products (ATMP) CDMO Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Advanced Therapy Medicinal Products (ATMP) CDMO Market?
To stay informed about further developments, trends, and reports in the Advanced Therapy Medicinal Products (ATMP) CDMO Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database
Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations
Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence
